23andMe Holding Co (ME)
3.465
+0.64
(+22.44%)
USD |
NASDAQ |
Nov 19, 13:34
23andMe Revenue (TTM): 193.26M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 193.26M |
| June 30, 2024 | 199.19M |
| March 31, 2024 | 219.64M |
| December 31, 2023 | 247.99M |
| September 30, 2023 | 270.18M |
| June 30, 2023 | 295.84M |
| March 31, 2023 | 299.49M |
| December 31, 2022 | 307.67M |
| Date | Value |
|---|---|
| September 30, 2022 | 297.62M |
| June 30, 2022 | 277.17M |
| March 31, 2022 | 271.89M |
| December 31, 2021 | 259.92M |
| September 30, 2021 | 258.50M |
| June 30, 2021 | 255.10M |
| March 31, 2021 | 243.92M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
193.26M
Minimum
Sep 2024
307.67M
Maximum
Dec 2022
259.82M
Average
259.92M
Median
Dec 2021
Revenue (TTM) Benchmarks
| RadNet Inc | 1.773B |
| iSpecimen Inc | 10.39M |
| Natera Inc | 1.532B |
| Progyny Inc | 1.139B |
| Delcath Systems Inc | 22.64M |